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In October 2003, 9 human cases of hemorrhagic 
fever were reported in 3 provinces of Mauritania, West Afri-
ca. Test results showed acute Rift Valley fever virus (RVFV) 
infection, and a ﬁ  eld investigation found recent circulation of 
RVFV with a prevalence rate of 25.5% (25/98) and 4 deaths 
among the 25 laboratory-conﬁ  rmed case-patients. Immuno-
globulin M against RVFV was found in 46% (25/54) of do-
mestic animals. RVFV was also isolated from the mosquito 
species Culex poicilipes. Genetic comparison of virion seg-
ments indicated little variation among the strains isolated. 
However, phylogenetic studies clearly demonstrated that 
these strains belonged to the East-Central African lineage 
for all segments. To our knowledge, this is the ﬁ  rst time vi-
ruses of this lineage have been observed in an outbreak in 
West Africa. Whether these strains were introduced or are 
endemic in West Africa remains to be determined.
R
ift Valley fever (RVF) is an acute febrile viral disease 
that affects small domestic ruminants (1) and humans. 
The disease in animals is characterized by high rates of 
abortion and death of young ruminants (2). In humans, the 
symptoms are usually mild, but in severe cases, hemor-
rhages, meningoencephalitis, retinopathy, and sometimes 
death can occur (3). The disease is widespread in Africa, 
mainly in the sub-Saharan region but also in Egypt. In 
2000, outbreaks were recorded for the ﬁ  rst time outside of 
the African continent, in Saudi Arabia and Yemen (4). RVF 
virus (RVFV) belongs to the family Bunyaviridae, genus 
Phlebovirus genus, and its genome consists of 3 negative 
single-stranded RNA segments referred to as L (large), M 
(medium), and S (small) (5).
In West Africa, the ﬁ  rst extensive RVF outbreak record-
ed to date occurred in Mauritania in 1987 and resulted in 220 
human deaths (6). After this outbreak, an active surveillance 
system led to the detection of several animal cases in Mau-
ritania, Senegal, and other West African countries (7–9). 
Furthermore, during interepizootic periods, RVFV has been 
repeatedly isolated from different mosquito species in Sen-
egal, Burkina Faso, and Nigeria (10–12,). During 1998, an 
outbreak of RVF occurred in southeastern Mauritania, re-
sulting in 300 to 400 human cases and 6 deaths (13).
In Mauritania in 2000, health authorities established 
a National Disease Surveillance System (NDSS) by using 
sentinel herds in 5 geographic regions and a notiﬁ  cation 
system of hemorrhagic fever in medical healthcare centers. 
This NDSS was implemented in collaboration with the 
Centre National d’Hygiène, the “Centre National d’Elevage 
et de Recherche Vétérinaire” in Mauritania, and the Insti-
tut Pasteur de Dakar in Senegal. The value of the NDSS 
was further reinforced after an outbreak of Crimean-Congo 
hemorrhagic fever in Mauritania in February 2003 (14) for 
which RVFV was identiﬁ  ed in animal and human serum 
specimens collected in September and October 2003. We 
describe the results of a multidisciplinary investigation to 
determine extent of the outbreak and the key factors re-
sponsible for RVFV reemergence in Mauritania.
Materials and Methods
Case Deﬁ  nitions
A suspected human RVFV case-patient was deﬁ  ned as 
a person with fever associated or not with hemorrhagic, 
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jaundice, or neurologic symptoms or any person who died 
who had had overt hemorrhagic fever symptoms from 
September through December 2003. A conﬁ  rmed human 
RVFV case-patient was deﬁ  ned as a person for whom labo-
ratory tests conﬁ  rmed an acute or recent RVFV infection, 
e.g., by >1 of these results: immunoglobulin M (IgM), re-
verse transcription–PCR (RT-PCR) or virus isolation posi-
tive results. A human contact was deﬁ  ned as any person or 
relative who had been directly in contact with a conﬁ  rmed 
human or animal case-patient, or with a person who died 
who had had overt hemorrhagic fever symptoms from Sep-
tember through December 2003.
Field Investigations
Study Sites
Nine localities belonging to 3 administrative provinces 
were visited (Figure 1): Keur Macène and Rkiz (Trarza 
Province), Makhtar Lahjar, Guimi, Taïba, and Sagle Moure 
(Brakna Province), Legrane, Kélébélé, and Hseytine (As-
saba Province). These localities were chosen because they 
had conﬁ  rmed human or animal cases.
Human Investigations
In affected areas, the investigation was conducted 
under the supervision of the chief of the sanitary district. 
For each case, venous or capillary blood samples were col-
lected into dry tubes or onto ﬁ  lter papers, respectively. A 
thick blood smear was also taken from all suspected case-
patients for differential diagnosis of malaria. An interview 
in which information was gathered about sex, age, date of 
fever onset, and hemorrhagic signs was conducted for all 
case-patients and their contacts.
Animal Investigations
All domestic animals living in the close vicinity of 
suspected or conﬁ  rmed case-patients were included in the 
study. Every blood sample was accompanied by an investi-
gation form specifying the species, age, and localization of 
the animal during the month before the investigation and, 
for female animals, a history of pregnancies.
Entomologic Investigations
Adult mosquitoes were collected in CDC light-traps 
(15), with or without CO2, which were placed close to 
water points or in sheepfolds, respectively; animal-baited 
traps were placed in the houses of persons with suspected 
or conﬁ  rmed cases. Mosquitoes were frozen and subse-
quently identiﬁ  ed on a chilled table by using morphologic 
keys (16,17). They were classiﬁ  ed into monospeciﬁ  c pools, 
stored in liquid nitrogen, and transported to the laboratory, 
where they were kept at –80°C until virus isolation was 
attempted.
Laboratory Tests
Serologic Studies
All human and animal samples were tested for evidence 
of IgG and IgM by using an ELISA technique (18,19). Se-
rum specimens were considered positive for antibodies if 
the difference between the sample and control optical den-
sities was >3 standard deviations above the mean of the 
negative controls.
Molecular Studies
Viral RNA was extracted from serum of suspected 
case-patients by using the QIAamp RNA kit (QIAGEN, 
Inc. Chatsworth, CA, USA) and RT-PCR was done by us-
ing the Titan One-Step RT-PCR System (Roche Diagnos-
tics, Mannheim, Germany), according to the recommenda-
tions of the manufacturers. The primers NS3a (nt 710–729; 
5′-ATGCTGGGAAGTGATGAGCG-3′) and NS2g (nt 
61–80; 5′-TGATTTGCAGAGTGGTCGTC-3′) were used 
to amplify a 669-nt region of the virus S segment region 
encoding the NSs protein. The primers MRV1a (nt 772–
790; 5′-CAAATGACTACCAGTCAGC-3′) and MRV2g 
(nt 1563–1580; 5′-GGTGGAAGGACTCTGCGA-3′) were 
used to amplify a 809-nt region of the virus M segment re-
gion encoding the G2 protein. Primers Wag (nt 4440–4457; 
5′-ATTCTTATTCCCGAATAT-3′) and Xg (nt 4634–4651; 
5′-TTGTTTTGCCTATCCTAC-3′) were used to amplify a 
212-nt region of the L segment (20–22). The PCR products 
were puriﬁ  ed on agarose gel and directly sequenced by us-
ing the Sanger method with an ABI 377 sequencer (Ap-
plied Biosystems, Foster City, CA, USA). Phylogenetic 
trees on the partial sequences of the S (601 nt), M (726 nt), 
and L (121 nt) RNA segments were constructed by using 
the maximum likelihood method (PAUP* 4.0, Sinauer As-
sociates Inc., Sunderland, MA, USA).
Virologic Studies
Virus isolation was performed at the World Health 
Organization (WHO) Collaborating Center for Arbovi-
Figure 1. Locations of the study sites.RESEARCH
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ruses (www.pasteur.fr/recherche/banques/crora), Insti-
tut Pasteur de Dakar on mosquitoes and serum collected 
from humans by inoculating the virus into suckling mice 
and a mosquito cell line (AP61). Virus identiﬁ  cation was 
performed by an indirect immunoﬂ  uorescence assay that 
used polyclonal and monoclonal antibodies. The identi-
ﬁ  cation of virus isolates was conﬁ  rmed by complement 
ﬁ  xation (23).
Parasitologic Test
To rule out malaria infection, thick blood smears from 
patients with suspected cases were Giemsa-stained. The ra-
tio of parasite (Plasmodium falciparum) to leukocytes was 
estimated in 200 ﬁ  elds based on a mean leukocyte count of 
8,000/μL of blood.
Results
Human Cases
The different cases recorded and the linkages between 
them are represented in Figure 2. The 9 conﬁ  rmed case-
patients, identiﬁ  ed before the investigation, were from the 
Assaba, Brakna, Trarza, and Tagant provinces. Subsequent 
discussions with the head of the sanitary district enabled 
the localization of the residences and the relatives for 2 of 
them (index case-patients 1 and 2). Several conﬁ  rmed cas-
es-patients (index case-patients 3 to 9) and their relatives 
were not found due to the great distances between locali-
ties or nomadic behaviors of populations. However, for all 
suspected case-patients (S), further investigation was con-
ducted in the provinces where the conﬁ  rmed case-patients 
lived.
In total, 98 persons (66 contacts, 23 with suspected 
cases, and 9 with conﬁ  rmed cases) were included in this 
study. Of these persons, 25.5% (25/98) had evidence of re-
cent RVFV infection (i.e., presence of IgM, viral RNA or 
virus, or >1 of these results), and 10% had evidence of past 
infection (i.e., presence of IgG alone). Seven viral strains 
were isolated. For the 25 patients who were recently in-
fected (9 with conﬁ  rmed cases before the investigation, 6 
contacts, and 10 with suspected cases at the time of investi-
gation), the median age was 21 years (range 7–50 years), 4 
died, and 16 had hemorrhagic signs (hematemesis, vaginal 
bleeding, severe hemoptysis, bleeding from the gums and 
venipuncture sites, petechial rashes, and ecchymoses of the 
skin). Among the 23 suspected case-patients from whom 
blood samples were collected, 10 were infected by RVFV; 
only 2 patients were positive for malaria parasites.
In Assaba Province, 2 conﬁ  rmed case-patients were re-
corded before the investigation (index case-patients 1 and 
2), and 1 suspected case-patient (S1) was found during the 
investigation. The index case-patient 1 was dead at the time 
of the investigation; however, RVFV (strain SHM169867) 
was isolated from a blood sample taken during his illness. 
No RVFV infection was noticed in contact persons associ-
ated with this patient. However, IgM against RVFV was 
detected in animals living in and near the residence of in-
dex case-patient 1. For index case-patient 2 (infected with 
the strain SHM169872), a second blood sample was taken, 
and presence of IgM antibodies against RVFV was con-
ﬁ  rmed. No evidence of RVFV infection was detected in 
contact persons or in animals living in or near the residence 
of this patient. The suspected case-patient 1 was identiﬁ  ed 
in Kiffa Hospital, where he was admitted on November 3, 
2003. This 50-year-old patient had onset of fever on Octo-
ber 24, 2003, with asthenia, jaundice, nausea, hematemesis, 
epistaxis, and gingival hemorrhage. Serologic tests showed 
IgM against RVFV. No evidence of virus infection was 
detected in those who had accompanied this patient to the 
hospital.
In Brakna Province, where 3 cases were conﬁ  rmed 
before the investigation (index case-patients 3–5), 6 sus-
pected case-patients (S2–S7) were found during the inves-
tigation. Laboratory testing of samples from the 3 index 
case-patients showed IgM against RVFV by ELISA and 
RVF viral RNA by RT-PCR. A virus strain (SHM169898) 
was isolated from index case-patient 4. Among the sus-
pected case-patients from this province, 3 deaths (S2–S4) 
were recorded, but no samples were available from those 
patients. Nevertheless, animals in the vicinity of S1, S2, 
and S3, were found to be infected (5/7, 5/8, and 3/10 ani-
mals, respectively). In addition, infection was detected in 4 
of 6 persons who had been in contact with suspected case-
patient 3. In contrast, no evidence of infection by RVFV 
was detected in contacts of S2 and S4. The suspected case-
Figure 2. Investigation of human and animal contact around index 
and suspected case-patients (S) from Mauritania in 2003. For each 
case-patient (represented as a box), PCR, immunoglobulin M 
(IgM), or isolation (Isol)-positive test results are indicated below the 
sample number (e.g., 169867). (a/b), no. IgM positive/no. tested; S*, 
suspected case-patient before ﬁ  eld investigation and subsequently 
conﬁ  rmed positive by laboratory tests. Rift Valley Fever Outbreak
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patient 5 was a student living in Makhtar Lahjar, who had 
fever onset on October 20, 2003, was admitted to the Na-
tional Hospital Center (NHC) of Nouakchott on November 
6, and from whose blood RVFV (strain SHM172776) was 
subsequently isolated. During the investigation, 2 suspected 
case-patients (S6 and S7) were discovered in the Healthcare 
Center of Makhtar Lahjar. Suspected case-patient 6 was a 
17-year-old female patient who had onset of fever on Oc-
tober 10 and who was admitted to the center on November 
1 with headache, abdominal pain, vomiting, hemorrhages, 
and epistaxis; virus was isolated from this patient (strain 
SHM172805). The contacts associated with suspected 
case-patient 6 were also found to be infected with RVFV. 
Suspected case-patient 7 was a 35-year-old man. He had a 
fever on October 15 and was admitted to the Health Center 
of Makhtar Lahjar on November 1 with headache, nausea, 
vomiting, and epistaxis. The RVF IgM test result for this 
patient was positive for RVFV.
In Trarza Province, 2 conﬁ  rmed case-patients were 
observed during the period of surveillance (index case-
patients 6 and 7) and 4 suspected case-patients (S8–S11) 
were identiﬁ  ed during the investigation. Viral isolation was 
positive for the index case-patient 7 (strain SHM169885). 
Among the suspected case-patients, 2 (S8 and S9) died 
before blood samples could be obtained. However, blood 
testing of samples from 2 animals living in the vicinity of 
S8 and from 2 human contacts of S9 found recent RVFV 
infection. Suspected case-patient 10 was 28-year-old man, 
with onset of fever on October 22, who came for consulta-
tion to Keur Macene Healthcare Center. He had a prolonged 
cough without hemorrhagic symptoms, and an IgM ELISA 
result for RVFV was positive. The suspected case-patient 
11 is a 26 year-old woman, with onset of fever on October 
22, who was admitted to the healthcare center of Rkiz with 
headaches, asthenia and anorexia without hemorrhagic 
signs.  The RVF IgM test result of this patient was positive. 
In Tagant Province, index case-patient 8, whose condition 
was diagnosed before the investigation, was a man who 
came for consultation at the provincial hospital on Septem-
ber 24, exhibiting fever and hematemesis. RVFV (strain 
SHM169868) was isolated from a blood sample taken on 
September 29.
In Gorgol Province, 2 suspected case-patients (S12 and 
S13) were evacuated to the NHC of Nouakchott. The onset 
of their symptoms dated to October 23 and October 25, re-
spectively. Samples from each were positive for IgM against 
RVFV by October 30, and RVFV (strain SHM172768) was 
isolated from S13, who died on October 30.
In Dakar, Senegal, an “imported” case (index case-pa-
tient 9) in a person from Rosso, Mauritania, was diagnosed 
by positive results by ELISA IgM and RT-PCR. This pa-
tient was ﬁ  rst admitted to the NHC of Nouakchott, Mauri-
tania, before being transferred to the Hôpital Principal de 
Dakar.
Animal Cases
Serum samples were obtained and tested from 54 do-
mestic animals (48 goats and 6 sheep) living in the visited 
localities (Table 1). The median age was 4 years (range 
1–15), and the abortion rate was 70% during the last gesta-
tion period. IgM against RVFV was detected by ELISA in 
25 of 54 animals; no IgG against RVFV was found in any 
of the 54. Among the animals with a positive test result, the 
abortion rate was 92%.
Mosquitoes
A total of 22,201 mosquitoes, belonging to 4 genera 
and 17 species, were collected. Culex poicilipes was the 
most frequent species (43.8%), followed by Cx. antenna-
tus (23%) and Mansonia uniformis (9%). A total of 544 
Table 1. Prevalence rate of immunoglobulin M against Rift Valley fever virus in livestock from Mauritania, 2003 
Livestock species (no. positive/no. tested) 
District/Locality Month  sampled  Sheep Goats Total
No. abortions/ 
no. tested 
Brakna
 Taiba  Oct 0/1 3/9 3/10 6/10
 Guimi  Oct 1/1 4/7 5/8 8/8
 Sagle  Moure  Nov 0/0 5/7 5/7 5/7
13/25 (42%)  19/25 (76%) 
Trarza 
 Boynayé  Oct 0/3 0/6 0/9 0/9
 Rkiz  Oct 0/0 2/2 2/2 2/2
2/11 (18%)  2/11 (18%) 
Assaba
 Legrane  Nov 0/1 2/5 2/6 5/6
 Kélébélé  Nov 0/0 1/2 1/2 2/2
 Tézékré  Nov 0/0 1/2 1/2 2/2
 Hseytine  Nov 0/0 6/8 6/8 8/8
10/18 (55%)  17/18 (94%) 
Total 1/6 (16%)  24/48 (50%)  25/54 (39%)  38/54 (70%) RESEARCH
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monospeciﬁ  c pools were constituted and submitted for vi-
ral isolation. Only Cx. poicilipes was found to be associated 
with RVFV. Three strains (ArD 174367, ArD 174303, and 
ArD 174347) were isolated from the 146 pools constituted 
in Guimi Province, giving rise to a minimum infection rate 
of 0.04% for this locality and 0.01% for the whole study 
site (Table 2).
Genetic Analysis
RNA was extracted from the 8 viral strains isolated 
from humans, and fragments of the S, M, and L segments 
were ampliﬁ  ed and sequenced. No amino acid (aa) dif-
ferences were found between the fragments of the S or L 
segments analyzed (198 and 51 aa, respectively). A single 
amino acid difference was found between the M fragment 
(255 aa) of the 5 viral strains analyzed. Results of phylo-
genetic analyses of the nucleotide sequences of ampliﬁ  ed 
fragments from 3 segments belonging to 2 representa-
tive strains (H1MAU03 [SHM169867] and H2MAU03 
[SHM169868]) isolated during this epidemic and previ-
ously described nucleotide sequences of RVFV are shown 
in Figure 3. The strains identiﬁ  ed in Mauritania 2003 are 
consistently located within the East/Central lineage for all 
trees. This lineage contains viral strains that circulated in 
Madagascar (1991), Kenya (1997), Chad (2001), and Saudi 
Arabia (2001).
Discussion
The combination of ELISA, RT-PCR, and isolation 
assays has permitted the rapid and efﬁ  cient identiﬁ  cation 
of RVFV as the cause of the extended hemorrhagic fever 
outbreak reported in Mauritania during the last quarter of 
2003. Of the 24 RVF cases diagnosed in the laboratory, 13 
were diagnosed by IgM only; 8 were diagnosed by IgM, 
RT-PCR, isolation, or >1 method; and 3 were diagnosed by 
RT-PCR, isolation, or both. These data and those obtained 
during the epidemics of RVF in Kenya (25), as well as in 
Saudi Arabia and Yemen (4), demonstrate the importance 
of combining diagnostic assays for accurate and compre-
hensive detection of RVFV infection.
Regarding differential diagnosis, only 2 suspected 
case-patients with fever had conﬁ  rmed malaria due to in-
fection by P. falciparum. This low malaria infection rate 
suggests that the RVF outbreak was the major cause of the 
febrile cases notiﬁ  ed during this period.
Although WHO estimates that the human mortality 
rate due to RVFV is ≈1%–2% of infected patients, the num-
ber of recorded deaths during this outbreak was 4 among 25 
infected patients when the laboratory data were considered 
exclusively. Epidemiologic investigations have found 5 ad-
ditional deaths that could be due to RVFV infection. We 
cannot be absolutely certain about the causes of death in 
our suspected case-patients from whom no blood sample 
was taken. However, when the clinical symptoms and the 
rate of infection in domestic animals are considered, that 
these cases were the result of RVFV infection is highly 
probable. In those cases in which the contacts had negative 
test results and only domestic animals had positive results, 
we hypothesize that the infection of those with lethal cases 
was related to socioeconomic/professional activity. Indeed, 
those at highest risk include butchers and others who come 
in contact with animals (e.g., slaughterhouse workers, tan-
ners, and herdsmen), who represent a large part of the pop-
ulation living in these areas.
During this investigation, a high infection rate was 
found in sheep and goats that lived in close proximity to 
the patients (46.3% of IgM positive compared with 25% 
during the 1998 outbreak) (13). Also, according to inter-
views with herdsmen, a high abortion rate (92%) was ob-
served in infected animals during their most recent preg-
nancy. Previous studies showed abortion rates ranging 
from 80% to 100% (26). Nevertheless, the discrepancies 
Table 2. Mosquitoes collected during the Rift Valley fever outbreak, Mauritania, 2003 
Culex
antennatus Cx. poicilipes
Cx.
tritaeniorhynchus
Mansomia 
uniformis Others* Total
Locality  CPCPC P CP C P C P
K. Macene  273 8 420 12 195 5 1,755 67 365 18 3,008 110
Boynayé 46 1 137 4 766 17 159 5 667 14 1,775 41
Techtayatt 696 14 290 7 451 9 30 1 627 15 2,094 46
Aleg 1,694 35 1437 30 155 3 69 2 435 12 3,790 82
Taiba 2,243 45 255 7 38 2 540 17 3,076 71
Boghe 16 3 16 3
Guimi 159 3 7163 146† 943 21 8,265 170
Legrane 6 1 14 2 20 3
Kélébélé 11 2 23 4 34 6
Hseytine  83 8 3
Sarandougu 8 1 18 1 3 1 86 6 115 9
Total 5,119 107 9,737 210 1,608 37 2,013 75 3,724 87 22,201 544
*Aedes. vexans, Ae. ochraceus, Anopheles funestus, An. gambiae, An. pharoensis, An. rufipes, An. wellcomei, An. ziemanni, An. squamosus,
Cx. ethiopicus,Cx. neavei and Ma. African. C, collected; P, pools. 
†Rift Valley fever virus strains (ArD 174367, ArD 174303, and ArD 174347) isolated in 3 pools. Rift Valley Fever Outbreak
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 7, July 2007  1021 
observed between the overall abortion rate in animals and 
the prevalence of anti-RVF IgM (70% vs 46.3%) support 
the hypothesis of the existence of other cocirculating dis-
eases that also cause abortion. The lack of anti-RVF IgG in 
domestic animals is surprising considering the long-stand-
ing virus endemicity in Mauritania. This observation could 
be ascribed to different factors: 1) the small number of do-
mestic animals analyzed, 2) a recent introduction of the vi-
rus in these localities, or 3) a renewal of animal populations 
(27). The latter hypothesis is supported by the observation 
of the relatively young median age of the animals tested 
(4 years old), reﬂ  ecting a new animal population since the 
1998 RVF epidemic in Mauritania.
Among the mosquitoes collected, several species 
known as RVFV vectors (Cx. poicilipes, Cx. tritaenio-
rhynchus, Cx. antennatus,  An. pharoensis,  Ae. vexans, 
Ae. ochraceus, and Ma. africana) (10,28) were recorded, 
but only Cx. poicilipes was found to carry RVFV dur-
ing the outbreak. Spatial analyses of the results show that 
Cx. poicilipes was in fact predominant only in the village 
of Guimi, where the RVFV was isolated. This observa-
tion indicates that the levels of the different species vary 
according to the local environment. Mosquitoes from the 
Aedes genus, known for their role in RVFV maintenance 
and transmission, were scarce, likely due to their early 
appearance at the onset of the rainy season, whereas our 
investigation took place at the end of the rainy season. 
Indeed, in 2003, the last rainfall event was recorded at the 
beginning of October.
Genetic analyses of the 3 segments of RVFV isolated 
during this epidemic showed a low level of variation be-
tween isolates from the different provinces. This ﬁ  nding 
supports the hypothesis that the same strain was circulating 
in the different affected areas. The nucleotide sequences 
of the strains isolated during this epidemic compared 
with those isolated elsewhere in Africa and Saudi Arabia 
showed that they belong to the East/Central African cluster 
for the 3 segments. Previous reports have shown that some 
strains isolated in West Africa share 1 or 2 segments with 
strains belonging to the East/Central African cluster (2,29). 
However, to our knowledge, this is the ﬁ  rst evidence of the 
circulation in West Africa of strains harboring 3 segments 
that all belong to the East/Central African cluster. 
This ﬁ  nding conﬁ  rms the existence of RVFV strain 
exchanges between geographic areas. In fact, the spread of 
RVFV from East Africa to other regions has already been 
observed during the RVF outbreak in Saudi Arabia and Ye-
men in 2000–2001 (4) and in Chad in 2001 (30). RVFV 
was also found to be the cause of the epidemic/epizootic 
in Egypt in 1977 and in Madagascar in 1979 (31). Such 
a mechanism of RVFV spread likely depends on human 
and animal population movements for which animal migra-
tion routes between West and East/Central Africa need to 
be identiﬁ  ed. Furthermore, previous studies have demon-
strated that reassortant viruses can emerge when 2 RVFV 
lineages coexist (24). Favorable environmental conditions 
(mainly the rainfall pattern), which led to the emergence 
of already introduced East/Central African strains, seem to 
Figure 3. Phylogenetic relationships of the S (small), M (medium), and L (large) RNA segments of Rift Valley fever viruses. Strains isolated 
in Mauritania (gray shading) are designated H1MAU03 and H2MAU03, according to previous abbreviation guidelines (24). Nucleotide 
sequences of these segments (S, M, and L) have been submitted to GenBank with the following accession nos., respectively: EF160113, 
EF160116, and EF160117 for H1MAU03; EF160114, EF160115, and EF160118 for H2MAU03. Branch lengths are proportional to the 
number of substitutions per site.RESEARCH
1022  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 7, July 2007
be the cause of this outbreak. Indeed, RVFV emergence 
in East Africa is undoubtedly the consequence of rainfall 
surplus (32,33). In contrast, in West Africa, the few studies 
carried out in the past indicate that rainfall surplus is not a 
key factor for RVFV emergence. In fact, RVF outbreaks 
were often observed during years of rainfall deﬁ  cit (10,34). 
Therefore, this outbreak in Mauritania, caused by RVFV 
strains of the East/Central African lineage, is likely linked 
to the heavy rainfall recorded during 2003 in the affected 
areas (315 mm in 2003 versus 161 mm in 2002). These ar-
guments support the hypothesis that episodes of heavy rain-
falls are directly or indirectly more favorable to the emer-
gence of virus strains belonging to the East/Central African 
cluster. However, such a hypothesis presumes the existence 
of ecologic or biologic differences between strains of the 2 
lineages, and further investigations are needed with special 
emphasis on the interactions with the strains’ respective 
vectors and reservoirs.
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